Clinically Proven by Gynecologists
The development of Neogyn was inspired by clinical research regarding wound healing conducted at the University Hospital of Lausanne, Switzerland, a leading international medical research facility. A cream containing Cutaneous Lysate was developed from this research and by coincidence, the cream was also found to be beneficial for the care of vulvar discomfort. The first report came from a researcher at the University Hospital using the cream for this purpose. Working with leading experts in feminine care for several years following, a new cream containing Cutaneous Lysate, Neogyn Vulvar Soothing Cream, was developed specifically to help soothe and calm the vulva.
Since then, a large number of women have benefited from the cream. The cream was studied in more than 200 women by two gynecologists in Switzerland. Most recently, a controlled study realized by gynecologist Professor G. Donders (Belgium), corroborated the positive results. More information can be found at www.vulvodyniatreatment.com.
In parallel, an additional controlled study was recently completed in the United States by Dr. Andrew Goldstein. Dr. Goldstein is an internationally recognized vulvar diesease specialist from The Centers for Vulvovaginal Disorders in Washington DC and New York. He is also the co-author of "When Sex Hurts" (Da Capo Press, 2011, ISBN 978-0-7382-1398-9).
The benefits of Neogyn were demonstrated in this clinical study of 30 patients with lichen sclerosus. Itching, burning and pain were significantly reduced after using the Neogyn Vulvar Soothing Cream twice daily for three months.
Dr. Goldstein presented the results of the study in September, 2011 at The International Society for the Study of Vulvovaginal Disease (ISSVD), “XXI World Congress” held in Paris, France.
*WARNING: The presentation contains photographs of the study participants with vulvar lichen sclerosus.